Feasibility study examining the short-term effects of Sonic Augmentation Technology™

BackgroundThe current study evaluated Sonic Augmentation Technology™ (SAT), a novel, Polyvagal-informed probe that incorporates continuously varying and acoustic features modeled on patterns of autonomic regulation into musical soundscapes. Specifically, the study examined whether SAT led to improvements in self-reported biobehavioral state (e.g. relaxation, breathing slowly, interoceptive clarity), and whether individuals with poorer baseline functioning (i.e., increased autonomic reactivity and anxiety/depression symptoms) reported greater improvements in biobehavioral state following SAT. It also sought to determine whether there would be changes in endogenous oxytocin level, and whether individuals who exhibit larger gains in biobehavioral state would show greater increases in oxytocin.MethodsThe current study examined data obtained from four samples, with 72 participants providing data virtually and 41 participants providing data in-person. Participants completed self-report measures of biobehavioral state, autonomic reactivity, and psychiatric symptomatology (i.e. anxiety and depression). Salivary oxytocin (pg/mL) was assessed via enzyme immunoassay in the participants who completed the study in person, with samples collected pre-and post-SAT.ResultsFollowing SAT, participants reported significant improvements in total biobehavioral state and the low and high arousal subscales. We also found that participants scoring above the cutoff for autonomic reactivity, anxiety, and depression reported greater increases in total biobehavioral state and decreases in the high arousal subscale. Greater decreases in the low arousal subscale were observed in the participants with increased anxiety. The subset of participants with salivary oxytocin samples exhibited increases in salivary oxytocin.ConclusionsThus, our results support the potential of SAT as a low-cost, non-invasive auditory probe for improving wellbeing, especially for clinical populations experiencing autonomic dysregulation and psychiatric difficulties, such as anxiety and depression.Clinical trial registrationClinicalTrials.gov, identifiers NCT06710886, NCT06902506, NCT06580119, and NCT07065227.

Social connectedness in mobile gaming: how family dynamics shape children’s virtual interactions

BackgroundMobile gaming is important for children’s social interaction, but its impact on real-life social connectedness depends heavily on family dynamics. How family patterns shape children’s emotional and social experiences around gaming remains underexplored, particularly qualitatively. This study examined how family dynamics influence children’s belonging, emotion regulation, and virtual interactions in mobile gaming.MethodsUsing a phenomenological design, we conducted semi-structured interviews with 20 participants from 10 families across urban, suburban, and rural China. Participants included children (n=10, aged 10-12), parents (n=8, all mothers), and siblings (n=2). All children had played mobile games for ≥6 months. Data were analyzed via thematic analysis (Braun & Clarke). Family patterns were identified based on parental mediation, emotional communication, and children’s sense of connectedness.ResultsThree family patterns emerged. Restrictive-Control Families (4/8) showed high monitoring and low trust, linked to concealment, tension, and social shift to virtual peers. Supportive Co-Play Families (3/8) exhibited shared play, emotional communication, and digital-offline continuity, with children reporting greater resilience and belonging. Sibling-Mediated Families (3 families) featured siblings as companions and emotional buffers, helping manage frustration without direct parental involvement. No severe conflicts or distress were directly caused by gaming in any pattern.ConclusionsChildren’s mobile gaming outcomes are shaped by relational context, not just time. This study identifies three family-level regulatory mechanisms: suppression (restrictive-control), cognitive reappraisal (supportive co-play), and co-regulation (sibling-mediated). These findings extend Social Connectedness Theory, showing how family patterns shape children’s emotion regulation. Supportive co-play and sibling mediation facilitate adaptive regulation and connectedness, while restrictive-control may drive children to virtual spaces. Family-based interventions targeting emotion regulation, not just screen reduction, are recommended. Shifting from “anti-addiction” to “developmental enhancement” offers a safe, practical strategy for integrating gaming into family life.

Major readouts from the annual diabetes conference

Good morning. Remember when the streets were covered in snow? The passage of time is so wild. Below we’ve got some news to start another week. 

Readouts from the annual diabetes conference

The American Diabetes Association’s annual conference in New Orleans wraps up today, after three days of data readouts, presentations, and, unexpectedly, a police interaction? Here are some highlights:

Read the rest…

Single-cell spatial pharmacobiology for imaging antibody-based therapies in solid tumors

Nature Biotechnology, Published online: 08 June 2026; doi:10.1038/s41587-026-03171-8

We have developed single-cell spatial pharmacobiology (SSP), which combines in situ imaging of a systemically infused fluorescent therapeutic antibody with high-plex spatial proteomics. Applied to head and neck and pancreatic tumors from patients treated in phase 1 trials, SSP revealed marked spatial heterogeneity in antibody delivery and target engagement, which was shaped by conserved stromal barriers.

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

Nature Medicine, Published online: 08 June 2026; doi:10.1038/s41591-026-04439-x

In a whole-exome sequencing analysis, the beneficial effects of the SGLT2 inhibitor dapagliflozin in reducing the risk of future heart failure hospitalization in individuals with type 2 diabetes were markedly greater in individuals who carried a cardiomyopathy-associated genetic variant compared with noncarriers, suggesting a personalized preventative therapy based on genetic information.